Your browser doesn't support javascript.
loading
Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.
Kampouri, Eleftheria; Little, Jessica S; Rejeski, Kai; Manuel, Oriol; Hammond, Sarah P; Hill, Joshua A.
Affiliation
  • Kampouri E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Little JS; Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Rejeski K; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Manuel O; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Hammond SP; Department of Medicine III-Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Hill JA; German Cancer Consortium (DKTK), Munich site, and German Cancer Research Center, Heidelberg, Germany.
Transpl Infect Dis ; 25 Suppl 1: e14157, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37787373

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Hematologic Neoplasms / Receptors, Chimeric Antigen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Dinamarca

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Hematologic Neoplasms / Receptors, Chimeric Antigen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Dinamarca